The GLP-1 Revolution: Miracle Drugs, Market Chaos, and the Cost of Slimness

Abstract

In modern society, unhealthy dietary patterns and sedentary lifestyles have made weight management a pressing challenge for many individuals. Therefore, people are seeking more effective approaches that fit contemporary living. Since 2021, GLP-1 receptor agonists have expanded beyond their original role in diabetes treatment and entered the field of weight control. As novel therapies, they provide effective weight reduction and lower risks of obesity-related diseases such as stroke, hypertension, and heart failure. This article explores the global rise of GLP-1 drugs, considering not only their clinical benefits but also the cultural and economic factors behind their popularity. Cultural norms, beauty standards, and social media have played an important role in fueling public enthusiasm. The trend is especially visible in the United States, China, and Japan, where differences in regulation and pricing strongly shape access. While GLP-1 drugs represent a significant advance, concerns about side effects and access highlight the need to weigh their benefits against potential risks.